Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Manjoo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|August 26, 2023
Oral semaglutide: an OASIS from injectablesPriya Manjoo, Arya M Sharma
Plos One|December 3, 2010
Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetesPriya Manjoo, Lawrence Joseph, Louise Pilote, et al.
BMJ Open Diabetes Research & Care|August 25, 2015
Utility of current obesity thresholds in signaling diabetes risk in the James Bay Cree of Eeyou IstcheePriya Manjoo, David Dannenbaum, Lawrence Joseph, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 29, 2025
Sue D Pedersen, Priya Manjoo, Satya Dash, et al.
Pain Medicine (Malden, Mass.)|May 5, 2018
Hormone Replacement Therapy and Opioid Tapering for Opioid-Induced Hypogonadism Among Patients with Chronic Noncancer Pain: A Systematic ReviewMahmood AminiLari, Priya Manjoo, Samantha Craigie, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 11, 2025
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline updateSue D Pedersen, Priya Manjoo, Satya Dash, et al.
Journal of Complementary & Integrative Medicine|May 9, 2013
Decreasing cardiovascular risk factors in obese individuals using a combination of PGX® meal replacements and PGX® granules in a 12-week clinical weight modification programRonald G Reichert, Michael R Lyon, Veronica Kacinik, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 16, 2023
Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonistsRonald M Goldenberg, Jeremy D Gilbert, Priya Manjoo, et al.
European Journal of Nutrition|July 10, 2020
Effect of a functional fibre supplement on glycemic control when added to a year-long medically supervised weight management program in adults with type 2 diabetesRaylene A Reimer, Sean Wharton, Tim J Green, et al.
CJC Open|June 23, 2022
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI StudyMilan Gupta, G B John Mancini, Rajvi J Wani, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|August 26, 2023
Oral semaglutide: an OASIS from injectablesPriya Manjoo, Arya M Sharma
Plos One|December 3, 2010
Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetesPriya Manjoo, Lawrence Joseph, Louise Pilote, et al.
BMJ Open Diabetes Research & Care|August 25, 2015
Utility of current obesity thresholds in signaling diabetes risk in the James Bay Cree of Eeyou IstcheePriya Manjoo, David Dannenbaum, Lawrence Joseph, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 29, 2025
Sue D Pedersen, Priya Manjoo, Satya Dash, et al.
Pain Medicine (Malden, Mass.)|May 5, 2018
Hormone Replacement Therapy and Opioid Tapering for Opioid-Induced Hypogonadism Among Patients with Chronic Noncancer Pain: A Systematic ReviewMahmood AminiLari, Priya Manjoo, Samantha Craigie, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 11, 2025
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline updateSue D Pedersen, Priya Manjoo, Satya Dash, et al.
Journal of Complementary & Integrative Medicine|May 9, 2013
Decreasing cardiovascular risk factors in obese individuals using a combination of PGX® meal replacements and PGX® granules in a 12-week clinical weight modification programRonald G Reichert, Michael R Lyon, Veronica Kacinik, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|November 16, 2023
Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high-dose GLP-1 receptor agonists and GLP-1 receptor-based co-agonistsRonald M Goldenberg, Jeremy D Gilbert, Priya Manjoo, et al.
European Journal of Nutrition|July 10, 2020
Effect of a functional fibre supplement on glycemic control when added to a year-long medically supervised weight management program in adults with type 2 diabetesRaylene A Reimer, Sean Wharton, Tim J Green, et al.
CJC Open|June 23, 2022
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI StudyMilan Gupta, G B John Mancini, Rajvi J Wani, et al.
Pageof 2